Terms: = Breast cancer AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Prognosis
32 results:
1. Application research of radiomics in colorectal cancer: A bibliometric study.
Yang L; Wang B; Shi X; Li B; Xie J; Wang C
Medicine (Baltimore); 2024 Apr; 103(15):e37827. PubMed ID: 38608072
[TBL] [Abstract] [Full Text] [Related]
2. Cholesterol-modified prognostic nutritional index (CPNI) as an effective tool for assessing the nutrition status and predicting survival in patients with breast cancer.
Shi J; Liu T; Ge Y; Liu C; Zhang Q; Xie H; Ruan G; Lin S; Zheng X; Chen Y; Zhang H; Song M; Zhang X; Hu C; Li X; Yang M; Liu X; Deng L; Shi H
BMC Med; 2023 Dec; 21(1):512. PubMed ID: 38129842
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Beta Blockers on breast cancer Incidence and prognosis.
Yang J; Zhang S; Jiang W
Clin Breast Cancer; 2023 Aug; 23(6):664-671.e21. PubMed ID: 37353431
[TBL] [Abstract] [Full Text] [Related]
4. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
[TBL] [Abstract] [Full Text] [Related]
5. COL11A1 as an novel biomarker for breast cancer with machine learning and immunohistochemistry validation.
Shi W; Chen Z; Liu H; Miao C; Feng R; Wang G; Chen G; Chen Z; Fan P; Pang W; Li C
Front Immunol; 2022; 13():937125. PubMed ID: 36389832
[TBL] [Abstract] [Full Text] [Related]
6. Detecting the expression of HRs and BCL2 via IHC can help identify luminal A-like subtypes of triple-positive breast cancers.
Xu Y; Liang Y; Yin G
Clin Transl Oncol; 2023 Apr; 25(4):1024-1032. PubMed ID: 36376700
[TBL] [Abstract] [Full Text] [Related]
7. Distinct clinicopathological characteristics, genomic alteration and prognosis in breast cancer with concurrent TP53 mutation and MYC amplification.
Lin X; Lin X; Guo L; Wang Y; Zhang G
Thorac Cancer; 2022 Dec; 13(24):3441-3450. PubMed ID: 36305094
[TBL] [Abstract] [Full Text] [Related]
8. Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in breast Ductal Carcinoma in situ.
Miligy IM; Toss MS; Gorringe KL; Ellis IO; Green AR; Rakha EA
Pathobiology; 2022; 89(6):382-392. PubMed ID: 35533650
[TBL] [Abstract] [Full Text] [Related]
9. Risk Factors, Prognostic Factors, and Nomogram for Distant Metastasis in breast cancer Patients Without Lymph Node Metastasis.
Min Y; Liu X; Hu D; Chen H; Chen J; Xiang K; Yin G; Han Y; Feng Y; Luo H
Front Endocrinol (Lausanne); 2021; 12():771226. PubMed ID: 34899606
[TBL] [Abstract] [Full Text] [Related]
10. The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS).
Al-Kawaz A; Ali R; Toss MS; Miligy IM; Mohammed OJ; Green AR; Madhusudan S; Rakha EA
Breast Cancer Res Treat; 2021 Nov; 190(1):39-51. PubMed ID: 34406589
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ.
Al-Kawaz A; Miligy IM; Toss MS; Mohammed OJ; Green AR; Madhusudan S; Rakha EA
Breast Cancer Res Treat; 2021 Jul; 188(1):53-63. PubMed ID: 34117958
[TBL] [Abstract] [Full Text] [Related]
12. The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population.
Gyan E; Green A; Ahenkorah-Fondjo L; Jackson A; Toss MS; Akakpo PK; Derkyi-Kwarteng L; Rahman GA; Owiredu W
Ann Diagn Pathol; 2021 Apr; 51():151696. PubMed ID: 33460998
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
[TBL] [Abstract] [Full Text] [Related]
14. Development of a risk-stratification scoring system for predicting lymphovascular invasion in breast cancer.
Ni-Jia-Ti MY; Ai-Hai-Ti DL; Huo-Jia AS; Wu-Mai-Er PL; A-Bu-Li-Zi AB; Shi Y; Rou-Zi NE; Su WJ; Dai GZ; Da-Mo-la MH
BMC Cancer; 2020 Feb; 20(1):94. PubMed ID: 32013960
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ.
Toss M; Miligy I; Gorringe K; Mittal K; Aneja R; Ellis I; Green A; Rakha E
J Clin Pathol; 2020 Feb; 73(2):76-82. PubMed ID: 31444238
[TBL] [Abstract] [Full Text] [Related]
16. The reciprocal influences of prognosis between two types of surgical interventions and early breast cancer patients with diverse luminal subtypes: A meta-analysis.
He L; Zhao S; Liu M; Su Z; Ren Y; Song Y
Medicine (Baltimore); 2019 Mar; 98(11):e14912. PubMed ID: 30882711
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ.
Toss MS; Miligy IM; Haj-Ahmad R; Gorringe KL; AlKawaz A; Mittal K; Ellis IO; Green AR; Rakha EA
Histopathology; 2019 Jun; 74(7):1025-1035. PubMed ID: 30725481
[TBL] [Abstract] [Full Text] [Related]
18. Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical-only ER-positive breast cancer.
Lv F; Jin WH; Zhang XL; Wang ZR; Sun AJ
J Cell Physiol; 2019 Jul; 234(7):11140-11148. PubMed ID: 30537139
[TBL] [Abstract] [Full Text] [Related]
19. Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ.
Toss MS; Miligy IM; Gorringe KL; McCaffrey L; AlKawaz A; Abidi A; Ellis IO; Green AR; Rakha EA
Mod Pathol; 2019 May; 32(5):639-649. PubMed ID: 30429518
[TBL] [Abstract] [Full Text] [Related]
20. prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registry.
Falato C; Taylor SK; Szulkin R; Nordblom A; Eriksson L; Sofiadis A; Fredriksson I; Hartman J; Bergh J; Foukakis T
Breast Cancer Res Treat; 2018 Dec; 172(3):703-712. PubMed ID: 30225620
[TBL] [Abstract] [Full Text] [Related]
[Next]
